Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Vanguard Index FdsTotal Stock Market | 1,038,550 | 1,038,550 | 0 | $300.98M | $285.44M | 21.71% | -$15.55M |
| Brookfield CorporationCL A(BN) | 2,798,830 | 2,330,830 | -468,000 | $160.79M | $122.16M | 9.29% | -$38.63M |
| Edgewise Therapeutics, Inc.(EWTX) | 5,000,000 | 5,350,000 | +350,000 | $133.50M | $117.70M | 8.95% | -$15.80M |
| Asml Holding N VN Y REGISTRY SHS N Y REGISTRY SHS | 165,836 | 165,836 | 0 | $114.94M | $109.89M | 8.36% | -$5.05M |
| Salesforce, Inc.(CRM) | 293,901 | 272,801 | -21,100 | $98.26M | $73.21M | 5.57% | -$25.05M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,500,000 | 1,500,000 | 0 | $62.02M | $67.58M | 5.14% | +$5.55M |
| Insmed Incorporated(INSM) | 724,666 | 724,666 | 0 | $50.03M | $55.28M | 4.21% | +$5.25M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 10,114,633 | 9,665,128 | -449,505 | $68.37M | $51.13M | 3.89% | -$17.25M |
| Alibaba Group Holding LimitedADS(BABA) | 452,327 | 372,327 | -80,000 | $38.35M | $49.23M | 3.75% | +$10.88M |
| Crinetics Pharmaceuticals In | 960,215 | 1,275,000 | +314,785 | $49.10M | $42.76M | 3.25% | -$6.33M |
| BioMarin Pharmaceutical Inc.(BMRN) | 490,000 | 490,000 | 0 | $32.21M | $34.64M | 2.63% | +$2.43M |
| ArriVent BioPharma, Inc.(AVBP) | 1,520,627 | 1,872,142 | +351,515 | $40.51M | $34.62M | 2.63% | -$5.89M |
| Vaxcyte, Inc.(PCVX) | 750,000 | 915,000 | +165,000 | $61.40M | $34.55M | 2.63% | -$26.84M |
| Merus N V | 750,000 | 789,129 | +39,129 | $31.54M | $33.21M | 2.53% | +$1.68M |
| Viridian Therapeutics, Inc.(VRDN) | 2,250,000 | 2,250,300 | +300 | $43.13M | $30.33M | 2.31% | -$12.80M |
| Pharvaris N V COM | 1,725,000 | 1,725,000 | 0 | $33.07M | $27.08M | 2.06% | -$5.99M |
| Amicus Therapeutics Inc COM | 2,500,000 | 2,750,000 | +250,000 | $23.55M | $22.44M | 1.71% | -$1.11M |
| Celldex Therapeutics, Inc.(CLDX) | 1,000,000 | 1,200,000 | +200,000 | $25.27M | $21.78M | 1.66% | -$3.49M |
| Blueprint Medicines Corp | 175,000 | 228,804 | +53,804 | $15.26M | $20.25M | 1.54% | +$4.99M |
| Zenas BioPharma, Inc.(ZBIO) | 1,600,000 | 2,214,967 | +614,967 | $13.10M | $17.50M | 1.33% | +$4.39M |
| CeriBell, Inc.(CBLL) | 328,809 | 880,000 | +551,191 | $8.51M | $16.90M | 1.29% | +$8.40M |
| Verve Therapeutics Inc | 2,400,000 | 3,000,000 | +600,000 | $13.54M | $13.71M | 1.04% | +$174.0K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,100,000 | 1,100,000 | 0 | $13.83M | $7.34M | 0.56% | -$6.49M |
| 4d Molecular Therapeutics In | 1,500,000 | 1,950,000 | +450,000 | $8.36M | $6.30M | 0.48% | -$2.06M |
| Lexeo Therapeutics, Inc.(LXEO) | 1,122,581 | 1,122,581 | 0 | $7.39M | $3.90M | 0.30% | -$3.49M |
| LanzaTech Global, Inc.(LNZA) | 15,814,845 | 15,814,845 | 0 | $21.67M | $3.83M | 0.29% | -$17.84M |
| Io Biotech Inc | 3,354,449 | 3,354,449 | 0 | $3.09M | $3.66M | 0.28% | +$570.3K |
| Kyverna Therapeutics, Inc.(KYTX) | 1,850,000 | 1,850,000 | 0 | $6.92M | $3.57M | 0.27% | -$3.35M |
| AbCellera Biologics Inc.(ABCL) | 1,126,915 | 1,126,915 | 0 | $3.30M | $2.51M | 0.19% | -$788.8K |
| Marqeta, Inc.CL A(MQ) | 441,558 | 441,558 | 0 | $1.67M | $1.82M | 0.14% | +$145.7K |
| Damora Therapeutics, Inc.(DMRA) | 99,913 | 99,913 | 0 | $464.6K | $309.7K | 0.02% | -$154.9K |
| Cargo Therapeutics Inc | 1,663,724 | 0 | -1,663,724 | $23.99M | $0 | — | -$23.99M |
| Mersana Therapeutics Inc. | 4,250,000 | 0 | -4,250,000 | $6.08M | $0 | — | -$6.08M |
| Tempus AI, Inc.CL A(TEM) | 4,074,419 | 0 | -4,074,419 | $137.55M | $0 | — | -$137.55M |